Research field (1)：
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (2)：
2022 - 2026 Treatment response and prognosis prediction of immune checkpoint inhibitors by FDG-PET/CT: A Japanese multicenter prospective study
2019 - 2022 Immune related gene-expression profiling for the combination of chemotherapy and PD-1/PD-L1 inhibition.
Papers (62)：
Naoki Shiraishi, Takayuki Takahama, Kazuko Sakai, Kaoru Tanaka, Yuzuki Nakagawa, Hiroaki Kanemura, Tomohiro Nakayama, Yusuke Kawanaka, Takashi Kurosaki, Shinichiro Suzuki, et al. Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene Testing. Thoracic Cancer. 2025
Yoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, Junji Tsurutani, Takeshi Yoshida, Kiyohiro Sakai, Miki Nakura, Ryo Sakamoto, Chihiro Makimura, Yoichi Ohtake, et al. Dual single-nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain. Molecular and clinical oncology. 2025. 22. 2. 14-14
Akiho Nagayama, Chiho Miyagawa, Yoko Kashima, Mamiko Ohta, Tomoyuki Otani, Takashi Kurosaki, Kohsuke Isomoto, Chiaki Inagaki, Takayuki Takahama, Kimio Yonesaka, et al. Malignant transformation of an ovarian mature teratoma diagnosed 17 years ago: a case report and literature review of treatment with immune checkpoint inhibitors. International Cancer Conference Journal. 2024
Masayuki Takeda, Masahide Ota, Eiji Iwama, Shunichi Sugawara, Takehito Shukuya, Shigeki Umemura, Hiroshi Tanaka, Masahide Oki, Takayuki Takahama, Takeshi Masuda, et al. A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial). Clinical lung cancer. 2024
Tomohiro Nakayama, Takayuki Takahama, Yasutaka Chiba, Naoki Shiraishi, Hisato Kawakami, Kimio Yonesaka, Kazuhiko Nakagawa, Hidetoshi Hayashi. Evaluation of immune checkpoint inhibitor efficacy for solid tumors withCD274(PD-L1 gene) amplification identified by comprehensive genomic profiling: retrospective study based on a nationwide database. Journal for ImmunoTherapy of Cancer. 2024. 12. 12
川中雄介, 米阪仁雄, 米阪仁雄, 稲垣千昌, 稲垣千昌, 高濱隆幸, 高濱隆幸, 白石直樹, 坂井和子, 西尾和人, et al. Drug Therapy Based on Cancer Genome Profiling (CGP, Comprehensive Genomic Profiling) in Lung Cancer. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2024. 28th
高濱隆幸, 磯本晃佑, 鈴木慎一郎, 渡邉諭美, 金村宙昌, 稲垣千晶, 三谷誠一郎, 谷崎潤子, 吉田健史, 田中薫, et al. Current Status and Issues of “imNET“ Activities of the Immune-Related Adverse Events Management Team in Kindai Hospital. 日本臨床腫瘍学会学術集会(CD-ROM). 2024. 21st
2003 - 2009 Kagawa University Faculty of Medicine School of Medicine
Professional career (1)：
M.D., Ph. D. (Kindai University)
Work history (9)：
2022/04 - 現在 Kindai University Kindai University Hospotal
2021/04 - 2022/03 Kindai University Department of medical oncology
2020/04 - 2021/03 Kindai University Nara Hospital Kindai University
2019/04 - 2020/03 Kindai University Nara Hospital Kindai University
2015/04 - 2019/03 Kindai University Faculty of Medicine
2013/04 - 2015/03 Kindai University Kindai University Hospotal
2012/04 - 2013/03 Kagawa University
2011/04 - 2012/03 Kagawa prefectural central hospital Respiratory medicine
2009/04 - 2011/03 Kagawa prefectural central hospital
Show all
Committee career (7)：
2024/02 - 現在 The Japanese society of medical oncology Specialist committee
2023/12 - 現在 International Association for the Study of Lung Cancer The Global Multidisciplinary Practice Standards Committee (GMPSC)
2023/05 - 現在 West Japan Oncology Group Education and Public Relations Committee
2022/04 - 現在 The Japanese Respiratory Society Adult Pneumonia Practice Guideline 2022 Preparation Committee Member of the Systematic Review Committee
2019/07 - 現在 Japanese Lung Cancer Society Guidelines Review Committee Subcommittee on Guidelines for Patients
2022/03 - 2024/02 Japan Society of Medical Oncology Member of the Supervisory Medical Examination Section
2017/07 - 2023/03 Ministry of Health, Labour and Welfare Commissioned Project for Training of Personnel Engaged in Genomic Medicine for Cancer Genomic Medicine Worker Training Committee
Show all
Awards (2)：
2020/09 - Nara medical association Nara medical association Young Researcher's Award
2017/05 - West Japan Oncology Group Ariyoshi/Fukuoka Prize
Association Membership(s) (8)：
THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
, THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY
, THE JAPANESE ASSOCIATION FOR INFECTIOUS DISEASES
, THE JAPAN LUNG CANCER SOCIETY
, THE JAPANESE RESPIRATORY SOCIETY
, THE JAPANESE CANCER ASSOCIATION
, 日本臨床腫瘍学会
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
